Global Direct-to-Consumer Genetic Testing Market

Global Direct-to-Consumer Genetic Testing (DTC-GT) Market: Focus on Direct-to-Consumer Genetic Testing Market by Product Type, Distribution Channel, 15 Countries Mapping, and Competitive Landscape - Analysis and Forecast, 2019-2028

The global direct-to-consumer market was valued at approximately $824.1 million in 2018 and is anticipated to reach $6,364.5 million by 2028.

SKU: BH125A
Published Year: 2019
 

The global direct-to-consumer genetic testing market consists of companies providing genetic testing services without the involvement of healthcare professionals. The DTC companies offer genetics testing services for ancestry, health and wellness and entertainment. Recent trends with regard to extensive funding from various investors for the promotion of genetic testing, are significantly propelling the market. Moreover, owing to the emerging concept of consumer empowerment, the global direct-to-consumer genetic test market is witnessing a massive influx of new entrants in the industry.

With the reduction in time required for genetic sequencing at an affordable cost has increased the acceptance of DTC testing among the consumers. The DTC companies offer these genetic tests to their consumers through online channel and OTC channels, further making these tests easily accessible to the consumers around the globe.

The purpose of the study is to gain a holistic view of the global direct-to-consumer genetic testing market in terms of various factors influencing it, such as recent trends and technological advancements of the market. The scope of this report is centered upon conducting a detailed study of the products allied with the direct-to-consumer genetic testing market, which include health and wellness-, entertainment- and ancestry-based genetic tests. The global direct-to-consumer genetic testing market is segmented into three different parts: by product-type, by distribution channel, and by region. The global market value was estimated on the basis of these three different approaches which were validated against one another. These segments are further sub-segmented to ease the market estimation. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.

This research report aims at answering various aspects of the global direct-to-consumer genetic testing market with the help of the key factors driving the market, restraints that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key ecosystem players and key strategies and developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities and challenges) and industry analysis as well.

The research study highlights the factors governing the industry attractiveness with Porter’s Five Forces for a comprehensive understanding of the global direct-to-consumer genetic testing market, and assesses the factors governing the same. Moreover, the study includes detailed product mapping, market estimation, and analysis of key trends in multiple countries, growth of direct-to-consumer genetic testing market in each country, and the key strategies and developments by the prominent manufacturers.

The answers to the following key questions can be derived from this report:

•    What are the major market drivers, challenges, and opportunities in the global direct-to-consumer genetic testing market?
•    What are the underlying structures resulting in the emerging trends within the direct-to-consumer genetic testing industry?
•    What was the market value of the leading segments and sub-segments of the global direct-to-consumer genetic testing market in 2018?
•    How is each segment of the global direct-to-consumer genetic testing market expected to grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2028?
•    What are the influencing factors that may affect the market share of the key players?
•    How is the industry expected to evolve during the forecast period 2019- 2028?
•    What are the key developmental strategies which are implemented by the key players to sustain in the competitive market?
•    What are the key product type in the global direct-to-consumer genetic testing market? What are the major benefits of each type?
•    What are the key distribution channel in the global direct-to-consumer genetic testing market? What are the major benefits of each type?
•    What is the market share of each of the companies in the global direct-to-consumer genetic testing market and what are their contributions?
•    Who are the key manufacturers in global direct-to-consumer genetic testing market, and what are their contributions?

The key players who have significant contributions to the direct-to-consumer genetic testing market are 23andme Inc., 24Genetics, Ancestry.com LLC, Atlas Biomed, Chengdu 23Mofang Biotechnology Co., Ltd., Dante Labs, Inc., EasyDNA, FamilyTreeDNA, Genebase Systems, Mapmygenome and MyHeritage Ltd. among others.

    Executive Summary
    1    Market Overview
          1.1    Bloom in Direct-to-Consumer Genetic Testing
          1.2    History Perspective
          1.3    Direct-to-Consumer Genetic Testing and Digital Technology Giants
 
    2    Market Dynamics
          2.1    Impact Analysis
          2.2    Growth Drivers
                   2.2.1    Curiosity Among Consumers
                   2.2.2    Rising Public Awareness
                   2.2.3    Need for Precision Medicine
                   2.2.4    Hassle-Free Model
          2.3    Growth Restraints
                   2.3.1    Lack of Regulation
                   2.3.2    Accuracy of Results
                   2.3.3    Ethical and Social Issues
          2.4    Growth Opportunities
                   2.4.1    Expanding the Services in an Untapped Market
                   2.4.2    Partnering with Physicians and Genetic Counselors
                   2.4.3    Initiating Education and Awareness Programs
                   2.4.4    Partnerships with Different Distribution Channels and Health Insurance
                   2.4.5    Expanding Product Portfolio
 
    3    Competitive Landscape
          3.1    Key Developments and Strategies
                   3.1.1    Product Launch and Upgrade
                   3.1.2    Collaborations, Agreements, and Partnerships
                   3.1.3    Product Approvals
                   3.1.4    Funding and Expansion
                   3.1.5    Acquisitions
          3.2    Market Share Analysis
          3.3    Industry Attractiveness
                   3.3.1    Bargaining Power of Suppliers
                   3.3.2    Bargaining Power of Buyers
                   3.3.3    Threats of New Entrants
                   3.3.4    Threats of Substitute Products
                   3.3.5    Intensity of Competitive Rivalry
 
    4    Industry Insights
          4.1    Legal Requirements and Regulations
          4.2    Regulation in North-America
                   4.2.1    The U.S.
          4.3    Regulation in Europe
                   4.3.1    Germany
                   4.3.2    France
                   4.3.3    The U.K.
                   4.3.4    Italy
                   4.3.5    Spain
          4.4    Regulation in APAC
                   4.4.1    China
                   4.4.2    Japan
                   4.4.3    Australia
                   4.4.4    South Korea
 
    5    Global DTC-GT Market (by Product Type)
          5.1    Ancestry
          5.2    Health and Wellness
          5.3    Entertainment
 
    6    Global DTC-GT Market (by Distribution Channel)
          6.1    Online Channel
          6.2    Over-the-Counter (OTC) Channel
 
    7    Global DTC-GT Market (by Region)
          7.1    North America
                   7.1.1    The U.S.
                   7.1.2    Canada
          7.2    Europe
                   7.2.1     Germany
                   7.2.2    France
                   7.2.3    The U.K.
                   7.2.4    Italy
                   7.2.5    Spain
          7.3    Asia-Pacific (APAC)
                   7.3.1    China
                   7.3.2    Japan
                   7.3.3    India
                   7.3.4    South Korea
                   7.3.5    Australia
          7.4    Latin America
                   7.4.1    Brazil
                   7.4.2    Mexico
                   7.4.3    Rest-of-Latin America (RoLA)
                   7.4.4    Rest-of-the-World
 
    8    Company Profiles
          8.1    Overview
          8.2    23andme Inc.
                   8.2.1    Company Overview
                   8.2.2    Role of 23andme Inc. in the Global DTC-GT Market
                   8.2.3    SWOT Analysis
          8.3    24Genetics
                   8.3.1    Company Overview:
                   8.3.2    Role of 24Genetics in Global DTC-GT Market
                   8.3.3    SWOT Analysis
          8.4    Ancestry.com LLC
                   8.4.1    Company Overview
                   8.4.2    Role of Ancestry.com LLC in the Global DTC-GT Market
                   8.4.3    SWOT Analysis
          8.5    Atlas Biomed
                   8.5.1    Company Overview
                   8.5.2    Role of Atlas Biomed in the Global DTC-GT Market
                   8.5.3    SWOT Analysis
          8.6    Chengdu 23Mofang Biotechnology Co., Ltd.
                   8.6.1    Company Overview
                   8.6.2    Role of Chengdu 23Mofang Biotechnology Co., in Global DTC-GT Market
                   8.6.3    SWOT Analysis
          8.7    Dante Labs, Inc.
                   8.7.1    Company Overview:
                   8.7.2    Role of Dante Lab Inc. in Global DTC-GT Market
                   8.7.3    SWOT Analysis:
          8.8    EasyDNA
                   8.8.1    Company Overview
                   8.8.2    Role of Easy DNA in Global DTC-GT Market
                   8.8.3    SWOT Analysis
          8.9    Family Tree DNA
                   8.9.1    Company Overview
                   8.9.2    Role of FamilyTreeDNA in Global DTC-GT Market
                   8.9.3    SWOT Analysis:
         8.10   Genebase Systems
                   8.10.1    Company Overview
                   8.10.2    Role of Genebase Systems in Global DTC-GT Market
                   8.10.3    SWOT Analysis
         8.11   Mapmygenome
                   8.11.1    Company Overview:
                   8.11.2    Role of Mapmygenome India Ltd. in Global DTC-GT Market
                   8.11.3    SWOT Analysis
         8.12   MyHeritage Ltd.
                   8.12.1    Company Overview
                   8.12.2    Role of MyHeritage Ltd in Global DTC-GT Market
                   8.12.3    SWOT Analysis
 
    9    Research Scope and Methodology
          9.1    Report Scope
 

List of Tables

Table 1:    List of DTC-GT Tests with Marketing Authorization by the U.S. FDA
Table 2:    Impact Analysis of Global DTC-GT Market
Table 2.1:    Impact Analysis
Table 4.1:    Regulations Governing Direct-to-Consumer Genetic Testing

List of Figures

Figure 1:    Genetic Health Risk Approval for DTC-GT by the U.S. FDA
Figure 2:    DTC-GT and GDPR in Europe, 2018
Figure 3:    False Positives in DTC-GT, Global, 2018
Figure 4:    Consumer Data Privacy, The U.S, 2017
Figure 5:    Reduction in Cost per Whole Genome, Global, 2012-2017
Figure 6:    Global DTC-GT Market, 2017-2028
Figure 7:    Dominating Segments of Global DTC-GT Market, 2018 and 2028
Figure 8:    Change in Market Share (%) of DTC-GT Product Segments, Global, 2018-2028
Figure 9:    Product Portfolio Assessment for Global DTC-GT Product Type Segment
Figure 10:    Global DTC-GT Market (by Distribution Channel), 2018 and 2028
Figure 11:    Distribution Model for DTC-GT Companies
Figure 12:    Business Model for DTC-GT Companies
Figure 13:    Global DTC-GT Market (by Region), 2018 and 2028
Figure 14:    Strategies Incorporated to Expand the Global Reach
Figure 15:    Market Lucrativeness for the New Entrants
Figure 16:    Go-To-Market Strategy
Figure 1.1:    DTC-GT Market Workflow
Figure 1.2:    Evolution of Global Direct-to-Consumer Genetic Testing
Figure 2.1:    Market Dynamics
Figure 2.2:    Market Opportunities
Figure 3.1:    Competitive Landscape, January 2014- February 2019
Figure 3.2:    Share of Key Developments and Strategies, January 2014- February 2019
Figure 3.3:    Market Share Analysis, 2017 and 2018
Figure 3.4:    Industry Attractiveness (Porter’s Five Forces Analysis)
Figure 3.5:    Bargaining Power of Suppliers: Overall Impact, 2019-2028
Figure 3.6:    Bargaining Power of Buyers: Overall Impact, 2019-2028
Figure 3.7:    Threat of New Entrants
Figure 3.8:    Threat of Substitute Products
Figure 3.9:    Intensity of Competitive Rivalry
Figure 5.1:    Global DTC-GT Market (by Product Type)
Figure 5.2:    Global DTC-GT Market (by Product Type), 2018-2028
Figure 5.3:    Global DTC-GT Market (by Ancestry), 2018-2028
Figure 5.4:    Global DTC-GT Market (by Health and Wellness), 2018-2028
Figure 5.5:    Global DTC-GT Market (by Entertainment), 2018-2028
Figure 6.1:    Global DTC-GT Market (by Distribution Channel), 2018-2028
Figure 6.2:    Global DTC-GT Market (by Distribution channel):
Figure 6.3:    Global DTC-GT Market (by Online Channel), 2018-2028
Figure 6.4:    Global DTC-GT Market (by Distribution Channel), 2018-2028
Figure 7.1:    Global DTC-GT Market (by Region), 2018-2028
Figure 7.2:    North America DTC-GT Market, 2018-2028
Figure 7.3:    North America DTC-GT Market (by Country), 2018-2028
Figure 7.4:    North America DTC-GT Market (by Product Type), 2018-2028
Figure 7.5:    The U.S. DTC-GT Market, 2018-2028
Figure 7.6:    Canada DTC-GT Market, 2018-2028
Figure 7.7:    Europe DTC-GT Market, 2018-2028
Figure 7.8:    Europe DTC-GT Market (by Country), 2018-2028
Figure 7.9:    Europe DTC-GT Market (by Product Type), 2018-2028
Figure 7.10:    Germany DTC-GT Market, 2018-2028
Figure 7.11:    France DTC-GT Market, 2018-2028
Figure 7.12:    The U.K.  DTC-GT Market, 2018-2028
Figure 7.13:    Italy DTC-GT Market, 2018-2028
Figure 7.14:    Spain DTC-GT Market, 2018-2028
Figure 7.15:    Asia-Pacific DTC-GT Market, 2018-2028
Figure 7.16:    Asia-Pacific DTC-GT Market (by Country), 2018-2028
Figure 7.17:    Asia-Pacific DTC-GT Market (by Product Type), 2018-2028
Figure 7.18:    China DTC-GT Market, 2018-2028
Figure 7.19:    Japan DTC-GT Market, 2018-2028
Figure 7.20:    India DTC-GT Market, 2018-2028
Figure 7.21:    South Korea DTC-GT Market, 2018-2028
Figure 7.22:    Australia DTC-GT Market, 2018-2028
Figure 7.23:    Latin America DTC-GT Market, 2018-2028
Figure 7.24:    Latin America DTC-GT Market (by Country), 2018-2028
Figure 7.25:    Latin America DTC-GT Market (by Product Type), 2018-2028
Figure 7.26:    Brazil DTC-GT Market, 2018-2028
Figure 7.27:    Mexico DTC-GT Market, 2018-2028
Figure 7.28:    Rest-of-Latin America DTC-GT Market, 2018-2028
Figure 7.29:    Rest-of-the-World DTC-GT Market, 2018-2028
Figure 8.1:    23andme Inc.: SWOT Analysis
Figure 8.2:    24Genetic: SWOT Analysis
Figure 8.3:    Ancestry.com LLC: SWOT Analysis
Figure 8.4:    Atlas Biomed: SWOT Analysis
Figure 8.5:    Chengdu 23Mofang Biotechnology Co., Ltd.: SWOT Analysis
Figure 8.6:    Dante Labs Inc.: SWOT Analysis
Figure 8.7:    EasyDNA: SWOT Analysis
Figure 8.8:    Family Tree DNA: SWOT Analysis
Figure 8.9:    Genebase Systems: SWOT Analysis
Figure 8.10:    Mapymygenome: SWOT Analysis
Figure 8.11:    MyHeritage Ltd: SWOT Analysis
Figure 9.1:    Global Direct-to-Consumer Genetic Testing: Market Segmentation
Figure 9.2:    Research Methodology
Figure 9.3:    Primary Research
Figure 9.4:    Secondary Research
Figure 9.5:    Data Triangulation
Figure 9.6:    Top-Down Approach (Segment-Wise Analysis)
Figure 9.7:    Bottom-up Approach (Segment-Wise Analysis)
Figure 9.8:    Assumptions and Limitations
Figure 9.9:    Considered Factors for Data Prediction and Modelling

The global direct-to-consumer market was valued at approximately $824.1 million in 2018 and is anticipated to reach $6,364.5 million by 2028. The rise in the public awareness along with the reduced cost and time required for sequencing owing to the technological advancements is responsible for bolstering the industry demand and aiding in reduction of the global healthcare expenditure. Furthermore, the recent developments in the regulatory pathway for the utilization of direct-to-consumer genetic tests for medical and research purposes have increased the acceptance of direct-to-consumer genetic testing.

Owing to the need for precision medicine, the genetic testing industry has been witnessing a surge in demand for genetic testing. The increased prevalence of genetic diseases such as cancer, Parkinson’s disease and rare diseases has led to the growth of global direct-to-consumer genetic testing market. The direct-to-consumer genetic testing does not follow traditional genetic regulations, wherein the consumer could directly order sample collection test kit online via company’s website and get an access to their genomic information by providing the sample of saliva or a cotton swab. Currently, the market is developing on regulations specific for direct-to-consumer genetic tests. The direct-to-consumer genetic testing enables the consumer to get tailor-made recommendation as per their genetic profile, further helping to reduce the potential risk of the conventional treatment. Adoption of the direct-to-consumer genetic testing has also lead to the framing of regulatory pathway for these tests along with the government initiations to raise the awareness among the consumers regarding these tests. These factors are expected to boost the growth of the industry in the forecast time. The emergence of direct-to-consumer genetic testing has enabled consumers to identify genetic diseases through genetic health risk tests and carrier predisposition tests. The direct-to-consumer genetic testing market also offers pharmacogenomics, nutrigenomics, ancestry and microbiome testing. The advent of the advanced genetic testing has improved the diagnosis and treatment, as well as enabled the genetic testing companies to meet the regulatory compliance, as well as to manage their profit margins.

The purpose of the study is to gain a holistic view of the global direct-to-consumer genetic testing market in terms of various factors influencing it, such as recent trends and technological advancements in the market. The scope of this report is centered upon conducting a detailed study of the products allied with the direct-to-consumer genetic testing market, which include health and wellness-, entertainment- and ancestry-based genetic tests. The global direct-to-consumer genetic testing market is segmented into three different parts: by product-type, by distribution channel, and by region. The global market value was estimated on the basis of these three different approaches which were validated against one another. These segments are further sub-segmented  to ease the market estimation.

With the increasing demand for personalized medicine, increasing incidence of chronic and rare diseases, technological advancements in sequencing industry and new product launches by several conglomerate companies, the global direct-to-consumer genetic testing market is expected to witness high growth. Moreover, the ancestry-based genetic test sub-segment dominated the global direct-to-consumer genetic testing market in 2018 in terms of products. However, the health and wellness genetic test segment is anticipated to witness the highest CAGR in the forecast period from 2019 to 2028. Besides the health-based genetic test, entertainment segment is also expected to witness impressive CAGR in the forecast period 2019-2028.

The global direct-to-consumer genetic testing market is segmented on the basis of geographical regions into North America, Europe, Asia-Pacific, Latin America and Rest-of-the-World (RoW). North America is the leading contributor in the global direct-to-consumer genetic testing market. However, the Rest-of-the-World is expected to grow at a CAGR of 17.93% in the forecast period 2019-2028. The global direct-to-consumer genetic testing market is majorly dominated by the U.S. The U.S.-based company 23andme contributed approximately more than 20% of the market value in 2018.

The key players who have significant contributions to the direct-to-consumer genetic testing market are 23andme Inc., 24Genetics, Ancestry.com LLC, Atlas Biomed, Chengdu 23Mofang Biotechnology Co., Ltd., Dante Labs, Inc., EasyDNA, FamilyTreeDNA, Genebase Systems, Mapmygenome and MyHeritage Ltd. among others.

We understand that your business need specific answers pertaining to the market. And , therefore, we do provide customised research tailored to your need.

With the purchase of this report, you are entitled to certain degree of free customisation within the scope of the study.

Do get in touch to help us understand how we can serve u better with a custom solution to your research needs. We assure quick turnaround for your pressing business requirements.

Contact Information


Name *
Email *
 
Company Name *
Designation*
 
 
Contact No. *
Other Details
 
 

Write the characters in the image above
 
 
* Required Fields

REQUEST SAMPLE
PLEASE SELECT A LICENSE TYPE
 
 
 

  REQUEST    SAMPLE

The global direct-to-consumer genetic testing market consists of companies providing genetic testing services without the involvement of healthcare professionals. The DTC companies offer genetics testing services for ancestry, health and wellness and entertainment. Recent trends with regard to extensive funding from various investors for the promotion of genetic testing, are significantly propelling the market. Moreover, owing to the emerging concept of consumer empowerment, the global direct-to-consumer genetic test market is witnessing a massive influx of new entrants in the industry.

With the reduction in time required for genetic sequencing at an affordable cost has increased the acceptance of DTC testing among the consumers. The DTC companies offer these genetic tests to their consumers through online channel and OTC channels, further making these tests easily accessible to the consumers around the globe.

The purpose of the study is to gain a holistic view of the global direct-to-consumer genetic testing market in terms of various factors influencing it, such as recent trends and technological advancements of the market. The scope of this report is centered upon conducting a detailed study of the products allied with the direct-to-consumer genetic testing market, which include health and wellness-, entertainment- and ancestry-based genetic tests. The global direct-to-consumer genetic testing market is segmented into three different parts: by product-type, by distribution channel, and by region. The global market value was estimated on the basis of these three different approaches which were validated against one another. These segments are further sub-segmented to ease the market estimation. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.

This research report aims at answering various aspects of the global direct-to-consumer genetic testing market with the help of the key factors driving the market, restraints that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key ecosystem players and key strategies and developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities and challenges) and industry analysis as well.

The research study highlights the factors governing the industry attractiveness with Porter’s Five Forces for a comprehensive understanding of the global direct-to-consumer genetic testing market, and assesses the factors governing the same. Moreover, the study includes detailed product mapping, market estimation, and analysis of key trends in multiple countries, growth of direct-to-consumer genetic testing market in each country, and the key strategies and developments by the prominent manufacturers.

The answers to the following key questions can be derived from this report:

•    What are the major market drivers, challenges, and opportunities in the global direct-to-consumer genetic testing market?
•    What are the underlying structures resulting in the emerging trends within the direct-to-consumer genetic testing industry?
•    What was the market value of the leading segments and sub-segments of the global direct-to-consumer genetic testing market in 2018?
•    How is each segment of the global direct-to-consumer genetic testing market expected to grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2028?
•    What are the influencing factors that may affect the market share of the key players?
•    How is the industry expected to evolve during the forecast period 2019- 2028?
•    What are the key developmental strategies which are implemented by the key players to sustain in the competitive market?
•    What are the key product type in the global direct-to-consumer genetic testing market? What are the major benefits of each type?
•    What are the key distribution channel in the global direct-to-consumer genetic testing market? What are the major benefits of each type?
•    What is the market share of each of the companies in the global direct-to-consumer genetic testing market and what are their contributions?
•    Who are the key manufacturers in global direct-to-consumer genetic testing market, and what are their contributions?

The key players who have significant contributions to the direct-to-consumer genetic testing market are 23andme Inc., 24Genetics, Ancestry.com LLC, Atlas Biomed, Chengdu 23Mofang Biotechnology Co., Ltd., Dante Labs, Inc., EasyDNA, FamilyTreeDNA, Genebase Systems, Mapmygenome and MyHeritage Ltd. among others.

    Executive Summary
    1    Market Overview
          1.1    Bloom in Direct-to-Consumer Genetic Testing
          1.2    History Perspective
          1.3    Direct-to-Consumer Genetic Testing and Digital Technology Giants
 
    2    Market Dynamics
          2.1    Impact Analysis
          2.2    Growth Drivers
                   2.2.1    Curiosity Among Consumers
                   2.2.2    Rising Public Awareness
                   2.2.3    Need for Precision Medicine
                   2.2.4    Hassle-Free Model
          2.3    Growth Restraints
                   2.3.1    Lack of Regulation
                   2.3.2    Accuracy of Results
                   2.3.3    Ethical and Social Issues
          2.4    Growth Opportunities
                   2.4.1    Expanding the Services in an Untapped Market
                   2.4.2    Partnering with Physicians and Genetic Counselors
                   2.4.3    Initiating Education and Awareness Programs
                   2.4.4    Partnerships with Different Distribution Channels and Health Insurance
                   2.4.5    Expanding Product Portfolio
 
    3    Competitive Landscape
          3.1    Key Developments and Strategies
                   3.1.1    Product Launch and Upgrade
                   3.1.2    Collaborations, Agreements, and Partnerships
                   3.1.3    Product Approvals
                   3.1.4    Funding and Expansion
                   3.1.5    Acquisitions
          3.2    Market Share Analysis
          3.3    Industry Attractiveness
                   3.3.1    Bargaining Power of Suppliers
                   3.3.2    Bargaining Power of Buyers
                   3.3.3    Threats of New Entrants
                   3.3.4    Threats of Substitute Products
                   3.3.5    Intensity of Competitive Rivalry
 
    4    Industry Insights
          4.1    Legal Requirements and Regulations
          4.2    Regulation in North-America
                   4.2.1    The U.S.
          4.3    Regulation in Europe
                   4.3.1    Germany
                   4.3.2    France
                   4.3.3    The U.K.
                   4.3.4    Italy
                   4.3.5    Spain
          4.4    Regulation in APAC
                   4.4.1    China
                   4.4.2    Japan
                   4.4.3    Australia
                   4.4.4    South Korea
 
    5    Global DTC-GT Market (by Product Type)
          5.1    Ancestry
          5.2    Health and Wellness
          5.3    Entertainment
 
    6    Global DTC-GT Market (by Distribution Channel)
          6.1    Online Channel
          6.2    Over-the-Counter (OTC) Channel
 
    7    Global DTC-GT Market (by Region)
          7.1    North America
                   7.1.1    The U.S.
                   7.1.2    Canada
          7.2    Europe
                   7.2.1     Germany
                   7.2.2    France
                   7.2.3    The U.K.
                   7.2.4    Italy
                   7.2.5    Spain
          7.3    Asia-Pacific (APAC)
                   7.3.1    China
                   7.3.2    Japan
                   7.3.3    India
                   7.3.4    South Korea
                   7.3.5    Australia
          7.4    Latin America
                   7.4.1    Brazil
                   7.4.2    Mexico
                   7.4.3    Rest-of-Latin America (RoLA)
                   7.4.4    Rest-of-the-World
 
    8    Company Profiles
          8.1    Overview
          8.2    23andme Inc.
                   8.2.1    Company Overview
                   8.2.2    Role of 23andme Inc. in the Global DTC-GT Market
                   8.2.3    SWOT Analysis
          8.3    24Genetics
                   8.3.1    Company Overview:
                   8.3.2    Role of 24Genetics in Global DTC-GT Market
                   8.3.3    SWOT Analysis
          8.4    Ancestry.com LLC
                   8.4.1    Company Overview
                   8.4.2    Role of Ancestry.com LLC in the Global DTC-GT Market
                   8.4.3    SWOT Analysis
          8.5    Atlas Biomed
                   8.5.1    Company Overview
                   8.5.2    Role of Atlas Biomed in the Global DTC-GT Market
                   8.5.3    SWOT Analysis
          8.6    Chengdu 23Mofang Biotechnology Co., Ltd.
                   8.6.1    Company Overview
                   8.6.2    Role of Chengdu 23Mofang Biotechnology Co., in Global DTC-GT Market
                   8.6.3    SWOT Analysis
          8.7    Dante Labs, Inc.
                   8.7.1    Company Overview:
                   8.7.2    Role of Dante Lab Inc. in Global DTC-GT Market
                   8.7.3    SWOT Analysis:
          8.8    EasyDNA
                   8.8.1    Company Overview
                   8.8.2    Role of Easy DNA in Global DTC-GT Market
                   8.8.3    SWOT Analysis
          8.9    Family Tree DNA
                   8.9.1    Company Overview
                   8.9.2    Role of FamilyTreeDNA in Global DTC-GT Market
                   8.9.3    SWOT Analysis:
         8.10   Genebase Systems
                   8.10.1    Company Overview
                   8.10.2    Role of Genebase Systems in Global DTC-GT Market
                   8.10.3    SWOT Analysis
         8.11   Mapmygenome
                   8.11.1    Company Overview:
                   8.11.2    Role of Mapmygenome India Ltd. in Global DTC-GT Market
                   8.11.3    SWOT Analysis
         8.12   MyHeritage Ltd.
                   8.12.1    Company Overview
                   8.12.2    Role of MyHeritage Ltd in Global DTC-GT Market
                   8.12.3    SWOT Analysis
 
    9    Research Scope and Methodology
          9.1    Report Scope
 

List of Tables

Table 1:    List of DTC-GT Tests with Marketing Authorization by the U.S. FDA
Table 2:    Impact Analysis of Global DTC-GT Market
Table 2.1:    Impact Analysis
Table 4.1:    Regulations Governing Direct-to-Consumer Genetic Testing

List of Figures

Figure 1:    Genetic Health Risk Approval for DTC-GT by the U.S. FDA
Figure 2:    DTC-GT and GDPR in Europe, 2018
Figure 3:    False Positives in DTC-GT, Global, 2018
Figure 4:    Consumer Data Privacy, The U.S, 2017
Figure 5:    Reduction in Cost per Whole Genome, Global, 2012-2017
Figure 6:    Global DTC-GT Market, 2017-2028
Figure 7:    Dominating Segments of Global DTC-GT Market, 2018 and 2028
Figure 8:    Change in Market Share (%) of DTC-GT Product Segments, Global, 2018-2028
Figure 9:    Product Portfolio Assessment for Global DTC-GT Product Type Segment
Figure 10:    Global DTC-GT Market (by Distribution Channel), 2018 and 2028
Figure 11:    Distribution Model for DTC-GT Companies
Figure 12:    Business Model for DTC-GT Companies
Figure 13:    Global DTC-GT Market (by Region), 2018 and 2028
Figure 14:    Strategies Incorporated to Expand the Global Reach
Figure 15:    Market Lucrativeness for the New Entrants
Figure 16:    Go-To-Market Strategy
Figure 1.1:    DTC-GT Market Workflow
Figure 1.2:    Evolution of Global Direct-to-Consumer Genetic Testing
Figure 2.1:    Market Dynamics
Figure 2.2:    Market Opportunities
Figure 3.1:    Competitive Landscape, January 2014- February 2019
Figure 3.2:    Share of Key Developments and Strategies, January 2014- February 2019
Figure 3.3:    Market Share Analysis, 2017 and 2018
Figure 3.4:    Industry Attractiveness (Porter’s Five Forces Analysis)
Figure 3.5:    Bargaining Power of Suppliers: Overall Impact, 2019-2028
Figure 3.6:    Bargaining Power of Buyers: Overall Impact, 2019-2028
Figure 3.7:    Threat of New Entrants
Figure 3.8:    Threat of Substitute Products
Figure 3.9:    Intensity of Competitive Rivalry
Figure 5.1:    Global DTC-GT Market (by Product Type)
Figure 5.2:    Global DTC-GT Market (by Product Type), 2018-2028
Figure 5.3:    Global DTC-GT Market (by Ancestry), 2018-2028
Figure 5.4:    Global DTC-GT Market (by Health and Wellness), 2018-2028
Figure 5.5:    Global DTC-GT Market (by Entertainment), 2018-2028
Figure 6.1:    Global DTC-GT Market (by Distribution Channel), 2018-2028
Figure 6.2:    Global DTC-GT Market (by Distribution channel):
Figure 6.3:    Global DTC-GT Market (by Online Channel), 2018-2028
Figure 6.4:    Global DTC-GT Market (by Distribution Channel), 2018-2028
Figure 7.1:    Global DTC-GT Market (by Region), 2018-2028
Figure 7.2:    North America DTC-GT Market, 2018-2028
Figure 7.3:    North America DTC-GT Market (by Country), 2018-2028
Figure 7.4:    North America DTC-GT Market (by Product Type), 2018-2028
Figure 7.5:    The U.S. DTC-GT Market, 2018-2028
Figure 7.6:    Canada DTC-GT Market, 2018-2028
Figure 7.7:    Europe DTC-GT Market, 2018-2028
Figure 7.8:    Europe DTC-GT Market (by Country), 2018-2028
Figure 7.9:    Europe DTC-GT Market (by Product Type), 2018-2028
Figure 7.10:    Germany DTC-GT Market, 2018-2028
Figure 7.11:    France DTC-GT Market, 2018-2028
Figure 7.12:    The U.K.  DTC-GT Market, 2018-2028
Figure 7.13:    Italy DTC-GT Market, 2018-2028
Figure 7.14:    Spain DTC-GT Market, 2018-2028
Figure 7.15:    Asia-Pacific DTC-GT Market, 2018-2028
Figure 7.16:    Asia-Pacific DTC-GT Market (by Country), 2018-2028
Figure 7.17:    Asia-Pacific DTC-GT Market (by Product Type), 2018-2028
Figure 7.18:    China DTC-GT Market, 2018-2028
Figure 7.19:    Japan DTC-GT Market, 2018-2028
Figure 7.20:    India DTC-GT Market, 2018-2028
Figure 7.21:    South Korea DTC-GT Market, 2018-2028
Figure 7.22:    Australia DTC-GT Market, 2018-2028
Figure 7.23:    Latin America DTC-GT Market, 2018-2028
Figure 7.24:    Latin America DTC-GT Market (by Country), 2018-2028
Figure 7.25:    Latin America DTC-GT Market (by Product Type), 2018-2028
Figure 7.26:    Brazil DTC-GT Market, 2018-2028
Figure 7.27:    Mexico DTC-GT Market, 2018-2028
Figure 7.28:    Rest-of-Latin America DTC-GT Market, 2018-2028
Figure 7.29:    Rest-of-the-World DTC-GT Market, 2018-2028
Figure 8.1:    23andme Inc.: SWOT Analysis
Figure 8.2:    24Genetic: SWOT Analysis
Figure 8.3:    Ancestry.com LLC: SWOT Analysis
Figure 8.4:    Atlas Biomed: SWOT Analysis
Figure 8.5:    Chengdu 23Mofang Biotechnology Co., Ltd.: SWOT Analysis
Figure 8.6:    Dante Labs Inc.: SWOT Analysis
Figure 8.7:    EasyDNA: SWOT Analysis
Figure 8.8:    Family Tree DNA: SWOT Analysis
Figure 8.9:    Genebase Systems: SWOT Analysis
Figure 8.10:    Mapymygenome: SWOT Analysis
Figure 8.11:    MyHeritage Ltd: SWOT Analysis
Figure 9.1:    Global Direct-to-Consumer Genetic Testing: Market Segmentation
Figure 9.2:    Research Methodology
Figure 9.3:    Primary Research
Figure 9.4:    Secondary Research
Figure 9.5:    Data Triangulation
Figure 9.6:    Top-Down Approach (Segment-Wise Analysis)
Figure 9.7:    Bottom-up Approach (Segment-Wise Analysis)
Figure 9.8:    Assumptions and Limitations
Figure 9.9:    Considered Factors for Data Prediction and Modelling

The global direct-to-consumer market was valued at approximately $824.1 million in 2018 and is anticipated to reach $6,364.5 million by 2028. The rise in the public awareness along with the reduced cost and time required for sequencing owing to the technological advancements is responsible for bolstering the industry demand and aiding in reduction of the global healthcare expenditure. Furthermore, the recent developments in the regulatory pathway for the utilization of direct-to-consumer genetic tests for medical and research purposes have increased the acceptance of direct-to-consumer genetic testing.

Owing to the need for precision medicine, the genetic testing industry has been witnessing a surge in demand for genetic testing. The increased prevalence of genetic diseases such as cancer, Parkinson’s disease and rare diseases has led to the growth of global direct-to-consumer genetic testing market. The direct-to-consumer genetic testing does not follow traditional genetic regulations, wherein the consumer could directly order sample collection test kit online via company’s website and get an access to their genomic information by providing the sample of saliva or a cotton swab. Currently, the market is developing on regulations specific for direct-to-consumer genetic tests. The direct-to-consumer genetic testing enables the consumer to get tailor-made recommendation as per their genetic profile, further helping to reduce the potential risk of the conventional treatment. Adoption of the direct-to-consumer genetic testing has also lead to the framing of regulatory pathway for these tests along with the government initiations to raise the awareness among the consumers regarding these tests. These factors are expected to boost the growth of the industry in the forecast time. The emergence of direct-to-consumer genetic testing has enabled consumers to identify genetic diseases through genetic health risk tests and carrier predisposition tests. The direct-to-consumer genetic testing market also offers pharmacogenomics, nutrigenomics, ancestry and microbiome testing. The advent of the advanced genetic testing has improved the diagnosis and treatment, as well as enabled the genetic testing companies to meet the regulatory compliance, as well as to manage their profit margins.

The purpose of the study is to gain a holistic view of the global direct-to-consumer genetic testing market in terms of various factors influencing it, such as recent trends and technological advancements in the market. The scope of this report is centered upon conducting a detailed study of the products allied with the direct-to-consumer genetic testing market, which include health and wellness-, entertainment- and ancestry-based genetic tests. The global direct-to-consumer genetic testing market is segmented into three different parts: by product-type, by distribution channel, and by region. The global market value was estimated on the basis of these three different approaches which were validated against one another. These segments are further sub-segmented  to ease the market estimation.

With the increasing demand for personalized medicine, increasing incidence of chronic and rare diseases, technological advancements in sequencing industry and new product launches by several conglomerate companies, the global direct-to-consumer genetic testing market is expected to witness high growth. Moreover, the ancestry-based genetic test sub-segment dominated the global direct-to-consumer genetic testing market in 2018 in terms of products. However, the health and wellness genetic test segment is anticipated to witness the highest CAGR in the forecast period from 2019 to 2028. Besides the health-based genetic test, entertainment segment is also expected to witness impressive CAGR in the forecast period 2019-2028.

The global direct-to-consumer genetic testing market is segmented on the basis of geographical regions into North America, Europe, Asia-Pacific, Latin America and Rest-of-the-World (RoW). North America is the leading contributor in the global direct-to-consumer genetic testing market. However, the Rest-of-the-World is expected to grow at a CAGR of 17.93% in the forecast period 2019-2028. The global direct-to-consumer genetic testing market is majorly dominated by the U.S. The U.S.-based company 23andme contributed approximately more than 20% of the market value in 2018.

The key players who have significant contributions to the direct-to-consumer genetic testing market are 23andme Inc., 24Genetics, Ancestry.com LLC, Atlas Biomed, Chengdu 23Mofang Biotechnology Co., Ltd., Dante Labs, Inc., EasyDNA, FamilyTreeDNA, Genebase Systems, Mapmygenome and MyHeritage Ltd. among others.

We understand that your business need specific answers pertaining to the market. And , therefore, we do provide customised research tailored to your need.

With the purchase of this report, you are entitled to certain degree of free customisation within the scope of the study.

Do get in touch to help us understand how we can serve u better with a custom solution to your research needs. We assure quick turnaround for your pressing business requirements.

Contact Information


Name *
Work Email *
 
Company Name *
Designation*
 
 
Contact No. *
Other Details
 
 

Write the characters in the image above
 
 
* Required Fields

Get yourself updated on key emerging technology markets

Know about our market intelligence coverage in key sectors